DAA Therapy in Hepatitis C in Patients With Chronic Kidney Disease: New Information for GFR Category G4 and G5 Reply

被引：0
|
作者：
Awan, Ahmed A. [1 ]
Jadoul, Michel [1 ]
Martin, Paul [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 20卷 / 01期
关键词：
D O I：
10.1016/j.cgh.2021.03.033
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [11] EFFECT OF TOLVAPTAN IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE G5 AND IMPACT OF CONCOMITANT USE OF THIAZIDE DIURETICS
    Uchiyama, Kiyotaka
    Kojima, Daiki
    Hama, Eriko Yoshida
    Nagasaka, Tomoki
    Nakayama, Takashin
    Takahashi, Rina
    Tajima, Takaya
    Morimoto, Kohkichi
    Washida, Naoki
    Itoh, Hiroshi
    JOURNAL OF HYPERTENSION, 2023, 41 : E386 - E386
  • [12] Similar Efficacy of Antiviral Therapy in Chronic Hepatitis C (CHC) Patients With Genotype 1 (G1) or Genotype 4 (G4). Results of a Large Nationwide Cohort Study
    Anagnostou, Olga
    Manolakopoulos, Spilios
    Bakoyannis, Giorgos
    Papatheodoridis, George
    Raptopoulou-Gigi, Maria
    Gogos, Charalampos
    Karatapanis, Stylianos
    Karaloulidou, Anastasia
    Kitis, George
    Touloumi, Giota
    GASTROENTEROLOGY, 2011, 140 (05) : S949 - S949
  • [13] Physical activity and renal outcome in diabetic and non-diabetic patients with chronic kidney disease stage G3b to G5
    Hoshino, Junichi
    Ohigashi, Tomohiro
    Tsunoda, Ryoya
    Ito, Yukiko
    Kai, Hirayasu
    Saito, Chie
    Okada, Hirokazu
    Narita, Ichiei
    Wada, Takashi
    Maruyama, Shoichi
    Pisoni, Ronald
    Pecoits-Filho, Roberto
    Yamagata, Kunihiro
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [14] Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies)
    Mou, Eric
    Advani, Ranjana H.
    von Eyben, Rie
    Rosenberg, Saul A.
    Hoppe, Richard T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (02): : 444 - 451
  • [15] UPDATE OF HEPATITIS C THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS
    Tartara, Silvina G.
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2017, 37 (03): : 172 - 182
  • [16] Daa Treatment Associated with Longer Survival in Swedish Patients with Chronic Hepatitis c (CHC) and Chronic Kidney Disease (CKD)
    Bruchfeld, Annette
    Carrero, Juan Jesus
    Salomonsson, Stina
    Lagerbaeck, Gunbritt
    Puenpatom, Amy
    Levin, Aaron
    Lindahl, Karin
    HEPATOLOGY, 2018, 68 : 891A - 891A
  • [17] Boccherini 'Cello Sonatas in A major G4, F minor, G major G5, C minor G2 & C major G17' - Naxos-8.554324 (Christian Benda, Sebastian Benda)
    Talbot, J
    STRAD, 1999, 110 (1312): : 875 - 875
  • [18] Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5
    Tanemoto, Masayuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (08) : 1045 - 1049
  • [19] Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5
    Masayuki Tanemoto
    Clinical and Experimental Nephrology, 2019, 23 : 1045 - 1049
  • [20] Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study
    Uchiyama, Kiyotaka
    Kojima, Daiki
    Hama, Eriko Yoshida
    Nagasaka, Tomoki
    Nakayama, Takashin
    Takahashi, Rina
    Tajima, Takaya
    Morimoto, Kohkichi
    Washida, Naoki
    Itoh, Hiroshi
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (04) : 649 - 657
12345